ADAP1 and colonic neoplasm: The two recurrent fusions (ADAP1‐NOC4L and RNF43‐SUPTH1) out of five chimeras were validated in SW48 and HT29 colon cancer cell lines as well as patient tissue samples (Figures 3, 4).